ASLAN’s Pan-HER Inhibitor Shows Positive Data In Gastric Cancer PhII Study
In Asia, a Phase II study conducted at Seoul National University Hospital, South Korea showed positive data in heavily pretreated people with... Read More
GSK’s breast cancer drug Tykerb fails in gastric cancer study
GlaxoSmithKline’s (GSK) intentions to expand the indication of personalised cancer drug Tyverb/ Tykerb took a blow when it failed to hit its... Read More
